secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001493152-26-001001
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics Health issues $3.125M convertible notes at 20% OID; sets 2026 target of 500 pharmacy onboardings/month
--------------------------------------------------------------------------------

- Issued up to $3,125,000 aggregate principal convertible notes; purchase price $2.5M (20% original issue discount).
- Notes mature at earlier of 6 months or close of $2M+ qualified equity financing; conversion floor price $0.08.
- Placement agent Dawson James Securities received 6.5% commission ($162,500) and warrants for 5% of gross proceeds.
- 2026 outlook: integrate EinsteinRx AI into pharmacy POS; target onboarding up to 500 pharmacies/month into Wellgistics Pharmacy Network.
- Company expanding manufacturer relationships for diabetes, GLP-1, and cardiometabolic drugs; PharmacyChain resource assessment ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226001001/0001493152-26-001001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226001001/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-001001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer